112 related articles for article (PubMed ID: 1370212)
1. Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Cancer; 1992 Jan; 69(2):410-2. PubMed ID: 1370212
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
3. Recovery of normal hematopoiesis after severe bone marrow aplasia induced by interferon-alpha in a patient with chronic myelogenous leukemia.
Hishida A; Yamamoto K; Kato C; Yokozawa T; Emi N; Tanimoto M; Saito H
Int J Hematol; 2003 Jan; 77(1):55-9. PubMed ID: 12568300
[TBL] [Abstract][Full Text] [Related]
4. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
[TBL] [Abstract][Full Text] [Related]
5. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
6. Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant.
Alabdulaaly A; Rifkind J; Solow H; Messner HA; Lipton JH
Leuk Lymphoma; 2004 Jan; 45(1):175-7. PubMed ID: 15061216
[TBL] [Abstract][Full Text] [Related]
7. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
Steegmann JL; Requena MJ; Casado LF; Pico M; Peñarrubia MJ; Ferro MT; Resino M; Fernandez-Rañada JM
Am J Hematol; 1996 Nov; 53(3):169-74. PubMed ID: 8895687
[TBL] [Abstract][Full Text] [Related]
8. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.
Claxton D; Deisseroth A; Talpaz M; Reading C; Kantarjian H; Trujillo J; Stass S; Gooch G; Spitzer G
Blood; 1992 Feb; 79(4):997-1002. PubMed ID: 1371081
[TBL] [Abstract][Full Text] [Related]
10. Therapy of chronic myelogenous leukaemia with interferons.
Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
[TBL] [Abstract][Full Text] [Related]
11. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia].
Tanabe Y; Dan K; Kuriya S; Nomura T
Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397
[TBL] [Abstract][Full Text] [Related]
12. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
[TBL] [Abstract][Full Text] [Related]
13. Successful allogeneic bone marrow transplant for chronic myeloid leukaemia despite previous interferon-induced cardiomyopathy.
Broady R; Hawkins T; Browett P; Palmer S
Bone Marrow Transplant; 1998 Apr; 21(8):833-4. PubMed ID: 9603410
[TBL] [Abstract][Full Text] [Related]
14. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
Srinivas U; Pillai LS; Kumar R; Pati HP; Saxena R
Am J Hematol; 2007 Apr; 82(4):314-6. PubMed ID: 17013815
[TBL] [Abstract][Full Text] [Related]
16. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
17. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
[TBL] [Abstract][Full Text] [Related]
18. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
Urabe A
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
McGlave PB; Arthur D; Miller WJ; Lasky L; Kersey J
Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
[TBL] [Abstract][Full Text] [Related]
20. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
